Medicare and Medicaid
Our work in Medicare and Medicaid
-
Did Medicare Part D Reduce Disparities?
This study assessed whether Medicare Part D reduced disparities in access to medication and found that the Part D coverage gap is disruptive to minorities and those living in low-income areas.
Categorized in -
Medicaid Access Restrictions on Psychiatric Drugs: Penny-Wise or Pound-Foolish?
Not only do formulary restrictions save little — if any — money on drug spending, they increase overall Medicaid spending for serious mental illnesses and may drive up incarceration costs.
-
The Value of Delaying Alzheimer’s Disease Onset
Models show that the number of patients will more than double in 40 years, and costs associated with their care will nearly quintuple.
Categorized in -
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?
The researchers analyzed the effects of oral nutritional supplement (ONS) use on 30-day readmission rates, length of stay (LOS), and episode costs in hospitalized Medicare patients (≥65), and subsets of patients diagnosed with acute myocardial infarction (AMI), congestive heart failure (CHF) or pneumonia (PNA), finding that ONS use was associated with improved outcomes and decreased healthcare costs, and is therefore relevant to providers seeking an inexpensive, evidence-based approach for meeting Affordable Care Act quality targets.
Categorized in -
The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare
This paper used the Future Elderly Model to estimate the effects of increased mortality gaps on the progressivity of Social Security and Medicare for those born between 1928 and 1990, and found that significant reductions in progressivity of both programs if current mortality trends persist and noticeable effects on total program costs.
Categorized in -
Quintiles Seminar Series – Spring: Jan-May 2014
The Quintiles Seminar Series is a biweekly seminar series that features prominent academics, researchers, policy makers, and industry leaders to discuss prevalent and current themes in health, policy, and economics.
Categorized in -
Nearly 60,000 Uninsured and Low-Income People with HIV/AIDS Live in States That Are Not Expanding Medicaid
Using national HIV surveillance data and data from the National Health Interview Survey, this study estimated that nearly 115,000 uninsured, low-income people living with HIV/AIDS would be eligible for Medicaid if all states adopted the Medicaid expansion sought by the Affordable Care Act.
Categorized in -
Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients with Schizophrenia and Bipolar Disorder in Medicaid
This study found that applying formulary restrictions to atypical antipsychotics is associated with higher total medical expenditures for patients with schizophrenia and bipolar disorder in Medicaid, and that, combined with the other social costs such as an increase in incarceration rates, these formulary restrictions could increase state costs by $1 billion annually, enough to offset any savings in pharmacy costs.
Categorized in -
Opioid Prescribing by Multiple Providers in Medicare: Retrospective Observational Study of Insurance Claims
This study found that concurrent opioid prescribing by multiple providers is common in Medicare patients and is associated with higher rates of hospital admission related to opioid use.
Categorized in -
Digesting the Doughnut Hole
Joyce, Zissimopoulos, and Goldman compare the use of prescription drugs among beneficiaries subject to the coverage gap (also known as the doughnut hole) with usage among beneficiaries who are not exposed to it.
Categorized in